Tumor Immunology and Immunotherapy

The molecular classification of Tumor is actually arrangement analysis disguised as classification. In a typical gene expression array study, the researcher will look at a cluster of tumors of a specific type. These therapies include nonspecific activation of the immune system using tollā€like receptor ligands, cytokines or immune checkpoint inhibitors, or specific treatments, like monoclonal antibody administration or vaccination, that directly target cancer cells. Cancers are not just masses of malignant cells but complex ‘rogue’ organs, to which many other cells are recruited and can be degraded by the transformed cells. Interactions between malignant and non-transformed cells create the  (TME).

 

<a data-cke-saved-href="" href="&quot;http://cancerimmunology.conferenceseries.com/registration.php&quot;" title="&quot;tumor" microenvironment"="">

    Related Conference of Tumor Immunology and Immunotherapy

    July 29-30 2019

    6th International Conference on Parasitology & Microbiology

    Amsterdam, Netherlands
    July 29-30, 2019

    11th Global Summit on Immunology and Cell Biology

    Sydney, Australia
    November 12-13, 2019

    13th International Congress on Autoimmunity

    Brisbane, Australia
    November 14-15, 2019

    International Conference on Vaccines and Immune Response

    Istanbul, Turkey
    November 14-15, 2019

    Annual Congress on Antibiotics and Antimicrobial Resistance

    Geneva, Switzerland
    November 21-22, 2019

    World Conference on Vaccine and Immunology

    Dubai, UAE

    Tumor Immunology and Immunotherapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in